Visão selecionada em Inglês
Descritor em português: | Rioprostila | ||||
Descritor em inglês: | Rioprostil | ||||
Descritor em espanhol: |
Rioprostilo
| ||||
Descritor em francês: | Rioprostil | ||||
Termo(s) alternativo(s): |
ORF 15927 ORF-15927 ORF15927 RWJ 15927 RWJ-15927 RWJ15927 TR 4698 TR-4698 TR4698 |
||||
Código(s) hierárquico(s): |
D10.251.355.255.550.775.450.750 D23.469.050.175.725.775.450.750 D23.469.700.660.750 |
||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D016630 | ||||
Nota de escopo: | A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies. |
||||
Qualificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Ação Farmacológica: |
Antiulcerosos |
||||
Número de registro: | 7JL402PVQR | ||||
Nome CAS Tipo 1: | Prost-13-en-9-one, 1,11,16-trihydroxy-16-methyl-, (11alpha,13E)- | ||||
Indexação Anterior: |
Anti-Ulcer Agents (1977-1991) Prostaglandins E (1975-1991) Prostaglandins, Synthetic (1977-1991) |
||||
Nota MeSH pública: | 92; RIOPROSTIL was indexed under PROSTAGLANDINS E 1985-91 |
||||
Nota Online: | use RIOPROSTIL (NM) to search RIOPROSTIL 1985-91 |
||||
Nota histórica: | 92; was RIOPROSTIL (NM) 1985-91 |
||||
Identificador DeCS: | 29838 | ||||
ID do descritor: | D016630 | ||||
Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||
Data de estabelecimento: | 01/01/1992 | ||||
Data de entrada: | 25/01/1991 | ||||
Data de revisão: | 08/06/2015 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Rioprostil
- Conceito preferido
TR-4698
- Mais específico
ORF-15927
- Mais específico
RWJ-15927
- Mais específico
Identificador do conceito |
M0025346 |
Nota de escopo | A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies. |
Termo preferido | Rioprostil |
Identificador do conceito |
M0351569 |
Termo preferido | TR-4698 |
Termo(s) alternativo(s) |
TR 4698 TR4698 |
Identificador do conceito |
M0351571 |
Termo preferido | ORF-15927 |
Termo(s) alternativo(s) |
ORF 15927 ORF15927 |
Identificador do conceito |
M0351570 |
Termo preferido | RWJ-15927 |
Termo(s) alternativo(s) |
RWJ 15927 RWJ15927 |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa